查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1657409

细胞分离市场 - 全球产业规模、份额、趋势、机会和预测，按产品、细胞类型、技术、应用、地区和竞争细分，2020-2030 年

Cell Separation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Cell Type, By Technique, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球细胞分离市场价值为 91.2 亿美元，预计到 2030 年将达到 155.1 亿美元，预测期内复合年增长率为 9.21%。全球细胞分离市场主要受到对先进诊断和治疗应用日益增长的需求的推动，特别是在个人化医疗、免疫疗法和癌症治疗领域。对干细胞研究和再生医学的日益关注也是一个重要因素，因为细胞分离技术对于分离这些应用的特定细胞类型至关重要。癌症、心血管疾病和自体免疫疾病等慢性疾病的发生率不断上升，刺激了对基于细胞的治疗和精准诊断的需求。微流体、磁激活细胞分选和萤光激活细胞分选等细胞分离方法的技术进步也透过提高效率和准确性促进了市场成长。学术和商业领域研究活动的扩展促进了细胞分离技术的广泛应用。

市场概况
预测期 2026-2030
2024 年市场规模 91.2 亿美元
2030 年市场规模 155.1 亿美元
2025-2030 年复合年增长率 9.21％
成长最快的领域 耗材
最大的市场 北美洲

主要市场驱动因素

精准医疗和免疫疗法的需求不断增长

慢性病盛行率上升

干细胞研究和再生医学的进展

细胞分离方法的技术进步

诊断工具需求不断成长

主要市场挑战

先进细胞分离技术成本高

细胞分离的技术限制和复杂性

主要市场趋势

增加对研究和医疗保健的资金和投资

生物製药产业成长

临床试验和细胞疗法的数量不断增加

分段洞察

产品洞察

细胞类型洞察

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第五章：全球细胞分离市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按产品（消耗品和仪器）
    • 依细胞类型（人类细胞和动物细胞）
    • 按技术（离心、表面标记和过滤）
    • 按应用（生物分子分离、癌症研究、干细胞研究、组织再生、体外诊断和治疗）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：北美细胞分离市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 加拿大
    • 墨西哥

第七章：欧洲细胞分离市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 英国
    • 义大利
    • 法国
    • 西班牙

第 8 章：亚太细胞分离市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：南美细胞分离市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲细胞分离市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 合併与收购（如有）
  • 产品发布（如果有）
  • 最新动态

第 13 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 14 章：竞争格局

  • Akadeum Life Sciences, Inc.
  • Corning Inc.
  • Merck & Co., Inc.
  • STEMCELL Technologies Canada Inc.
  • Bio-Rad Laboratories, Inc.
  • Terumo Corp.
  • Becton, Dickinson and Company
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.

第 15 章：策略建议

第16章 调査会社について・免责事项

简介目录
Product Code: 27657

Global Cell Separation Market was valued at USD 9.12 Billion in 2024 and is expected to reach USD 15.51 Billion by 2030 with a CAGR of 9.21% during the forecast period. The Global Cell Separation Market is primarily driven by the increasing demand for advanced diagnostic and therapeutic applications, particularly in personalized medicine, immunotherapy, and cancer treatment. The growing focus on stem cell research and regenerative medicine is also a significant factor, as cell separation techniques are crucial for isolating specific cell types for these applications. The rising prevalence of chronic diseases, such as cancer, cardiovascular conditions, and autoimmune disorders, has spurred the need for cell-based therapies and precise diagnostics. Technological advancements in cell separation methods, such as microfluidics, magnetic-activated cell sorting, and fluorescence-activated cell sorting, are also contributing to market growth by improving efficiency and accuracy. The expansion of research activities in academic and commercial settings is fostering increased adoption of cell separation technologies.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 9.12 Billion
Market Size 2030USD 15.51 Billion
CAGR 2025-20309.21%
Fastest Growing SegmentConsumables
Largest MarketNorth America

Key Market Drivers

Growing Demand for Precision Medicine and Immunotherapy

The growing demand for precision medicine and immunotherapy is a key driver of the Global Cell Separation Market. As personalized medicine continues to evolve, there is an increasing emphasis on providing individualized treatment options tailored to the unique genetic, molecular, and cellular characteristics of patients. Cell separation technologies are integral in this process, as they allow for the isolation and purification of specific cell populations, such as immune cells, stem cells, and cancer cells, from mixed cell populations. This ability to selectively target and analyze specific cell types is crucial for developing more effective, targeted therapies. In May 2024, researchers in China announced a potential cell therapy treatment for type 2 diabetes, offering promising news for millions affected by the condition. The study, published in the journal Cell Discovery, details the case of a 59-year-old man with type 2 diabetes who underwent a successful treatment. The procedure involved cultivating islet cells, which produce insulin, in the laboratory and then transplanting them into the patient, showing positive results.

Immunotherapy, which harnesses the body's immune system to fight diseases such as cancer, relies heavily on the use of specific immune cells, including T-cells, dendritic cells, and natural killer cells. Cell separation technologies enable the isolation of these cells from patient samples, facilitating the development of targeted immunotherapies. For example, techniques such as magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS) are commonly used to isolate immune cells from blood or tissue samples for further analysis or therapeutic purposes. This growing focus on immunotherapy and precision medicine, combined with advancements in cell separation technologies, is driving the demand for cell separation solutions.

The need for accurate and efficient cell separation is heightened by the increasing complexity of diseases, particularly cancers. Cancer is highly heterogeneous, with different subtypes and genetic variations present within a single tumor. As a result, the ability to isolate and analyze distinct cell populations is crucial for understanding the molecular mechanisms underlying cancer and for developing targeted treatments. Cell separation techniques play a critical role in isolating tumor cells or specific immune cells that can be used for immunotherapy, as well as in monitoring the progression of the disease.

Rising Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases, and autoimmune disorders is a significant driver of the Global Cell Separation Market. Chronic diseases often require long-term care, frequent monitoring, and specialized treatment regimens. In the U.S., it is estimated that 2,001,140 new cases of cancer will be diagnosed in 2024, with 611,720 deaths attributed to the disease. Among this, approximately 15,590 children and teenagers aged 0 to 19 are projected to die from cancer in 2024, out of an expected 14,910 new cases of the illness.

Cell separation technologies are critical for the diagnosis, management, and treatment of these diseases, particularly in identifying specific cell populations that contribute to disease progression or are targeted in therapeutic interventions. For instance, cancer immunotherapy relies on isolating tumor-infiltrating lymphocytes, while diabetes research often involves isolating stem cells for potential regenerative treatments. The rising burden of chronic diseases globally necessitates efficient cell separation techniques for early detection, therapeutic development, and personalized treatment strategies.

Advancements in Stem Cell Research and Regenerative Medicine

Stem cell research and regenerative medicine are gaining substantial momentum, further fueling the demand for cell separation technologies. Stem cells are crucial in treating various degenerative conditions and injuries by replacing damaged tissues and promoting regeneration. Researchers rely on advanced cell separation methods to isolate specific stem cell populations, whether from bone marrow, adipose tissue, or other sources. These isolated stem cells are then utilized for further research or therapeutic applications. As regenerative medicine continues to evolve, advancements in cell separation technologies that enable better isolation, characterization, and utilization of stem cells are vital. The increasing investment in stem cell-based treatments for a variety of diseases, including neurological disorders, orthopedic injuries, and cardiac diseases, continues to drive the demand for cell separation technologies.

Technological Advancements in Cell Separation Methods

Technological innovation in cell separation methods is a significant factor accelerating the growth of the Global Cell Separation Market. In August 2023, Bio-Rad Laboratories, Inc., a global leader in clinical diagnostic products and life science research, announced the launch of StarBright Red 670, its 29th StarBright dye. The company also introduced 29 additional highly validated antibodies conjugated to StarBright Blue 700 and StarBright Violet 610 dyes, expanding its current product range. This expanded selection enhances research possibilities in veterinary immunology by offering greater diversity and flexibility in both conventional and full-spectrum multicolor flow cytometry panels. In addition to more mouse and human targets, the range now includes targets for dog, cow, and pig.

Over the years, traditional techniques like density gradient centrifugation and magnetic bead-based separation have been enhanced by emerging technologies such as microfluidics, laser microdissection, and automated systems. These innovations have enabled more precise, efficient, and high-throughput separation of cell populations from complex mixtures. Microfluidic devices, for example, allow for real-time processing of small fluid volumes, which makes them highly beneficial in research and clinical settings where precision is paramount. Automated platforms for cell sorting, such as fluorescence-activated cell sorting (FACS) and automated MACS, streamline the process, reduce human error, and increase the overall efficiency of cell separation. As technology advances, the ability to separate cells with greater purity and accuracy drives the growth of the market by making these methods accessible to a wider range of clinical and research applications.

Growing Demand for Diagnostic Tools

Cell separation plays a vital role in diagnostic applications, particularly in the detection of cancers, infections, and genetic disorders. Technologies that allow for the isolation of specific cell populations from blood, bone marrow, or other bodily fluids are increasingly being used to identify disease markers, monitor treatment responses, and improve diagnostic accuracy. For example, isolating cancer cells from blood samples, known as liquid biopsy, is a rapidly growing area of interest in oncology. This non-invasive diagnostic technique can detect cancer early, even before symptoms appear. In September 2023, Akadeum Life Sciences, a global leader in buoyancy-based cell separation technology, unveiled their 'Human T Cell Activation & Expansion Kit,' featuring microbubbles for buoyancy-activated cell sorting (BACS). This innovative kit simplifies the process of T cell expansion, activation, and isolation from a sample, allowing all steps to be completed in a single, straightforward procedure.

As the demand for such diagnostic tools continues to grow, especially in personalized medicine, the Global Cell Separation Market is expected to expand, as the separation of specific cells is central to improving the effectiveness of these diagnostic tests.

Key Market Challenges

High Costs of Advanced Cell Separation Technologies

One of the major challenges hindering the growth of the Global Cell Separation Market is the high cost associated with advanced cell separation technologies. Cutting-edge techniques such as fluorescence-activated cell sorting (FACS), magnetic-activated cell sorting (MACS), and microfluidic-based systems require significant investment in infrastructure, training, and maintenance. These advanced systems often come with high initial purchase costs, operational expenses, and the need for specialized personnel, making them less accessible, particularly for smaller laboratories or healthcare facilities in developing regions. As a result, while larger research institutions and biopharmaceutical companies can absorb these costs, smaller players may face challenges in adopting such technologies. The cost factor remains a barrier for broader market adoption, limiting access to these tools in some areas, especially in low-resource settings.

Technical Limitations and Complexities in Cell Separation

Despite advancements in cell separation technologies, there are still significant technical limitations and complexities that affect their efficiency and accuracy. Some methods, such as density gradient centrifugation or immuno-magnetic separation, may struggle to achieve high purity or yield, particularly when working with heterogeneous samples. Isolating rare or hard-to-isolate cell populations, such as circulating tumor cells (CTCs) or stem cells from complex mixtures, remains a challenging task. The complexity of working with delicate cells, which may be sensitive to mechanical stress or environmental changes during separation, can result in reduced viability or functionality of the isolated cells. This can compromise the outcomes of research, diagnostics, and therapies. These technical challenges require continuous innovation in cell separation technologies to improve their reliability and efficiency.

Key Market Trends

Increased Funding and Investments in Research and Healthcare

The substantial growth in funding for biomedical research, healthcare, and pharmaceutical sectors is propelling the demand for cell separation technologies. Government organizations, private investors, and research institutions are increasingly investing in research related to cancer, stem cell therapy, immunotherapy, and regenerative medicine, all of which rely on efficient cell separation. Cell separation technologies are central to these research efforts, as they help researchers isolate the specific cells required for studying disease mechanisms and testing new therapies. Pharmaceutical companies are focusing more on cell-based therapies, and as they push forward in clinical trials, they require reliable cell separation tools for both patient treatment and drug development. The influx of funding and investments accelerates the adoption of advanced cell separation techniques, further driving market growth.

Growth of Biopharmaceutical Industry

The biopharmaceutical industry, which produces biological drugs derived from living organisms, is another significant driver of the Global Cell Separation Market. The biopharmaceutical sector is expanding rapidly due to the rising demand for biologic therapies, including monoclonal antibodies, gene therapies, and cell therapies, all of which require specific cell populations for their development and testing. For example, cell separation technologies are critical in producing high-quality therapeutic proteins or isolating immune cells for use in cancer immunotherapies. As biopharmaceutical companies ramp up their production of biologic drugs, the need for advanced cell separation solutions grows. Regulatory pressures for higher purity and more efficient processes in the production of biologic drugs are driving innovation in cell separation methods, making them more indispensable for the industry.

Increasing Number of Clinical Trials and Cell-Based Therapies

The growing number of clinical trials focused on cell-based therapies is also a key factor driving the Global Cell Separation Market. Clinical trials for gene therapies, stem cell therapies, and cancer immunotherapies, such as CAR T-cell therapy, often require precise and efficient cell separation methods to isolate the necessary cell populations from patient samples. As more therapies move from preclinical studies to clinical trials, the demand for high-quality cell separation technologies increases. With the rapid development of new cell-based treatments for a wide range of conditions, including rare diseases and neurological disorders, there is a growing need to isolate and analyze cells at various stages of therapy. This dynamic clinical trial landscape, coupled with the increasing number of investigational cell-based therapies, is driving the adoption of cell separation technologies.

Segmental Insights

Product Insights

Consumables are currently the fastest-growing segment of the market, surpassing instruments in both market share and growth. These consumables, which include reagents, magnetic beads, antibodies, cell culture media, and other essential materials, are critical for isolating specific cells from heterogeneous mixtures, making them indispensable in both research and clinical applications. As demand for cell separation continues to increase, driven by advances in personalized medicine, immunotherapy, and regenerative medicine, the consumption of these consumables has surged significantly.

A key factor fueling the growth of consumables is their recurring usage. Each cell separation process requires frequent replenishment of consumables, leading to consistent market expansion. Whether in research laboratories, hospitals, or biopharmaceutical manufacturing, consumables are used in large quantities with every separation procedure. As a result, they represent a significant portion of the revenue in the Global Cell Separation Market. Additionally, they are relatively more affordable than instruments, making them accessible to a wider range of users, from small research labs to large clinical facilities.

Advancements in cell separation technologies have spurred the development of more specialized and efficient consumables. For example, newer generations of magnetic beads and antibodies offer greater specificity and higher binding capacities, improving the efficiency and purity of cell isolation. These innovations are driving further demand for consumables as researchers and clinicians seek better outcomes in applications like cancer immunotherapy, stem cell therapy, and immune cell research. Consequently, there is an increasing focus on creating specialized consumables for different cell types, broadening their use in various therapeutic and diagnostic areas.

Cell Type Insights

Based on the Cell Type segment, human cells was dominating the market, driven by the increasing demand for cell-based therapies, personalized medicine, and immunotherapy. Human cell separation plays a crucial role in numerous applications, such as cancer immunotherapy, regenerative medicine, stem cell research, and diagnostic testing. The human cell segment is projected to continue its growth due to the rising prevalence of chronic diseases, growing demand for personalized healthcare, and advancements in therapeutic interventions involving human-derived cells.

One of the key drivers behind the dominance of human cells in the cell separation market is the expanding field of immunotherapy, especially in the treatment of cancers. For example, therapies like CAR T-cell therapy require the isolation and modification of T-cells from human blood, making human cell separation indispensable in these applications. These therapies are highly personalized, relying on cells from the patient's own body to fight cancer. Human cells are also crucial in regenerative medicine, where stem cells derived from human tissues are used to regenerate or repair damaged organs and tissues. The ability to isolate specific human cells, such as hematopoietic stem cells or mesenchymal stem cells, is essential for the development of stem cell-based therapies, further driving demand in the human cell separation market.

Regional Insights

North America was the dominant region, holding a significant share of the market. This dominance can be attributed to several factors, including strong healthcare infrastructure, significant investments in biotechnology and healthcare research, and a high demand for advanced technologies in clinical and research applications. North America, particularly the United States, is home to many of the world's leading biotechnology and pharmaceutical companies, academic institutions, and research centers. These institutions are at the forefront of developments in cell-based therapies, immunotherapies, and personalized medicine, all of which rely heavily on cell separation technologies.

The biopharmaceutical industry in North America is a major driver of the demand for cell separation solutions. The region's leading pharmaceutical companies and research organizations require advanced cell separation techniques for drug development, clinical trials, and biomanufacturing processes. For example, in cancer immunotherapy, therapies such as CAR T-cell therapy depend on the precise isolation and modification of patient-derived T-cells, making cell separation an essential step. As the biopharmaceutical sector continues to expand, the demand for cell separation technologies to support the development of new treatments and therapies is expected to remain high.

North America's strong position in healthcare innovation also contributes to the region's market dominance. The United States and Canada are home to numerous cutting-edge healthcare technologies, including automated cell separation systems, flow cytometry platforms, and microfluidic devices. These innovations allow for the high-throughput and efficient isolation of specific cell types for research, diagnostics, and therapeutic applications. The adoption of these advanced technologies in both academic and clinical settings is a key factor driving the market growth in North America. The region's regulatory environment, which supports the approval and commercialization of new medical technologies, has helped facilitate the widespread use of cell separation solutions in various sectors.

Key Market Players

  • Akadeum Life Sciences, Inc.
  • Corning Inc.
  • Merck & Co., Inc.
  • STEMCELL Technologies Canada Inc.
  • Bio-Rad Laboratories, Inc.
  • Terumo Corp.
  • Becton, Dickinson and Company
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.

Report Scope:

In this report, the Global Cell Separation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Separation Market, By Product:

  • Consumables
  • Instruments

Cell Separation Market, By Cell Type:

  • Human Cells
  • Animal Cells

Cell Separation Market, By Technique:

  • Centrifugation
  • Surface Marker
  • Filtration

Cell Separation Market, By Application:

  • Biomolecule Isolation
  • Cancer Research
  • Stem Cell Research
  • Tissue Regeneration
  • In Vitro Diagnostics
  • Therapeutics

Cell Separation Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Separation Market.

Available Customizations:

Global Cell Separation market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Separation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables and Instruments)
    • 5.2.2. By Cell Type (Human Cells and Animal Cells)
    • 5.2.3. By Technique (Centrifugation, Surface Marker, and Filtration)
    • 5.2.4. By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics, and Therapeutics)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Cell Separation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Cell Type
    • 6.2.3. By Technique
    • 6.2.4. By Application
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cell Separation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Cell Type
        • 6.3.1.2.3. By Technique
        • 6.3.1.2.4. By Application
    • 6.3.2. Canada Cell Separation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Cell Type
        • 6.3.2.2.3. By Technique
        • 6.3.2.2.4. By Application
    • 6.3.3. Mexico Cell Separation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Cell Type
        • 6.3.3.2.3. By Technique
        • 6.3.3.2.4. By Application

7. Europe Cell Separation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Cell Type
    • 7.2.3. By Technique
    • 7.2.4. By Application
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cell Separation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Cell Type
        • 7.3.1.2.3. By Technique
        • 7.3.1.2.4. By Application
    • 7.3.2. United Kingdom Cell Separation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Cell Type
        • 7.3.2.2.3. By Technique
        • 7.3.2.2.4. By Application
    • 7.3.3. Italy Cell Separation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Cell Type
        • 7.3.3.2.3. By Technique
        • 7.3.3.2.4. By Application
    • 7.3.4. France Cell Separation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Cell Type
        • 7.3.4.2.3. By Technique
        • 7.3.4.2.4. By Application
    • 7.3.5. Spain Cell Separation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Cell Type
        • 7.3.5.2.3. By Technique
        • 7.3.5.2.4. By Application

8. Asia-Pacific Cell Separation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Cell Type
    • 8.2.3. By Technique
    • 8.2.4. By Application
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Cell Separation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Cell Type
        • 8.3.1.2.3. By Technique
        • 8.3.1.2.4. By Application
    • 8.3.2. India Cell Separation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Cell Type
        • 8.3.2.2.3. By Technique
        • 8.3.2.2.4. By Application
    • 8.3.3. Japan Cell Separation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Cell Type
        • 8.3.3.2.3. By Technique
        • 8.3.3.2.4. By Application
    • 8.3.4. South Korea Cell Separation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Cell Type
        • 8.3.4.2.3. By Technique
        • 8.3.4.2.4. By Application
    • 8.3.5. Australia Cell Separation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Cell Type
        • 8.3.5.2.3. By Technique
        • 8.3.5.2.4. By Application

9. South America Cell Separation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Cell Type
    • 9.2.3. By Technique
    • 9.2.4. By Application
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Cell Separation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Cell Type
        • 9.3.1.2.3. By Technique
        • 9.3.1.2.4. By Application
    • 9.3.2. Argentina Cell Separation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Cell Type
        • 9.3.2.2.3. By Technique
        • 9.3.2.2.4. By Application
    • 9.3.3. Colombia Cell Separation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Cell Type
        • 9.3.3.2.3. By Technique
        • 9.3.3.2.4. By Application

10. Middle East and Africa Cell Separation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Cell Type
    • 10.2.3. By Technique
    • 10.2.4. By Application
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Cell Separation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Cell Type
        • 10.3.1.2.3. By Technique
        • 10.3.1.2.4. By Application
    • 10.3.2. Saudi Arabia Cell Separation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Cell Type
        • 10.3.2.2.3. By Technique
        • 10.3.2.2.4. By Application
    • 10.3.3. UAE Cell Separation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Cell Type
        • 10.3.3.2.3. By Technique
        • 10.3.3.2.4. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Akadeum Life Sciences, Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Corning Inc.
  • 14.3. Merck & Co., Inc.
  • 14.4. STEMCELL Technologies Canada Inc.
  • 14.5. Bio-Rad Laboratories, Inc.
  • 14.6. Terumo Corp.
  • 14.7. Becton, Dickinson and Company
  • 14.8. Agilent Technologies, Inc.
  • 14.9. Danaher Corporation
  • 14.10. Thermo Fisher Scientific, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer